Purpose: The utilization of controller medications before initiating a long-acting β 2-adrenergic agonist (LABA) before and after the Food and Drug Administration (FDA) alerts is examined. Methods: ...
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...
Atrogi AB, a clinical stage biotech company pioneering novel GPCR pathway-signalling modulators to transform metabolic and muscle health, today announces that the first subjects have been dosed in a ...
Overuse of rescue medication among asthma patients is associated with increased exacerbations and higher total and asthma-related healthcare costs. Objective: To assess whether increased short-acting ...
a FDA = Food and Drug Administration, COPD = chronic obstructive pulmonary disease. b p represents the level of significance for the comparison between patients who filled an initial prescription for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results